Investor Relations

At Gelteq we believe better delivery underpins better health outcomes. Gelteq® technology aims to address challenges associated with conventional drug and nutrient delivery by enhancing bioavailability, improving patient compliance, and enabling precise dosing. We are dedicated to delivering products that contribute to the commercial success of our partners whilst also improving the overall health of people.

Our primary focus is on advancing drug and nutrient delivery with Gelteq® technology. We specializes in research and development, product creation and manufacturing for partners across pharmaceutical, consumer health (supplements and functional foods) and animal health markets.

Stock Snapshot

Latest Financial Results

FY 2025

Fiscal Year Ended Jun 30, 2025

Latest Annual Filing

For Fiscal Year Ending Jun 30, 2025

Company Overview

Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a biotechnology company that has developed Gelteq® technology, a proprietary delivery technology designed to improve how active ingredients are formulated, stabilised and absorbed by the body.

Gelteq specializes in research and development, product creation and manufacturing for partners across pharmaceutical, consumer health and animal health markets. Gelteq® technology aims to address challenges associated with conventional drug and nutrient delivery by enhancing bioavailability, improving patient compliance, and enabling precise dosing.

Gelteq holds multiple patent families that cover a range of applications for our proprietary Gelteq® technology

IR Contacts

Company

Gelteq Limited
Monash Innovation Labs
G.60, 22 Alliance Lane
Clayton, Victoria 3800
Australia
T: +61 3 9087 3990
info@gelteq.com

Investor Relations

Gelteq
Nathan Givoni
CEO
Monash Innovation Labs
G.60, 22 Alliance Lane
Clayton 3800 Victoria
Australia
T: +61 3 9087 3990
ir@gelteq.com
https://www.gelteq.com


Darrow Associates
Matt Kreps
Managing Director
Austin, Texas
United States
T: 214-597-8200
mkreps@darrowir.com

Transfer Agent

Colonial Stock Transfer Co, Inc.
Kalysha Chandler
7840 S 700 E
Sandy, UT 84070
United States
T: 801-355-5740
Kalyshachandler@colonialstock.com
https://www.colonialstock.com